{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05919264",
            "orgStudyIdInfo": {
                "id": "FOG-001-101"
            },
            "organization": {
                "fullName": "Fog Pharmaceuticals, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "FOG-001 in Locally Advanced or Metastatic Solid Tumors",
            "officialTitle": "A Phase 1/2 Study of FOG-001 in Participants With Locally Advanced or Metastatic Solid Tumors",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "fog-in-locally-advanced-or-metastatic-solid-tumors"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-05-23",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-04-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-08-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-05-19",
            "studyFirstSubmitQcDate": "2023-06-21",
            "studyFirstPostDateStruct": {
                "date": "2023-06-26",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-28",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Fog Pharmaceuticals, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic cancer.",
            "detailedDescription": "This first-in-human, Phase 1/2, multicenter, open-label, non-randomized dose escalation and expansion study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and antitumor activity of FOG-001 in participants with locally advanced or metastatic solid tumors. FOG-001 is a first-in-class direct inhibitor of Beta-catenin, which functions by blocking its interaction with the T-cell factor (TCF) family of transcription factors."
        },
        "conditionsModule": {
            "conditions": [
                "Cancer",
                "Colorectal Cancer",
                "Solid Tumor",
                "Locally Advanced Solid Tumor",
                "Metastatic Cancer",
                "Gastric Cancer",
                "Non-small Cell Lung Cancer",
                "Non-small Cell Carcinoma",
                "Non-small Cell Lung Cancer Metastatic",
                "Non-small Cell Lung Cancer Stage IIIB",
                "Non-Small Cell Carcinoma of Lung, TNM Stage 4",
                "Gastroesophageal-junction Cancer",
                "WNT Pathway",
                "\u03b2-catenin",
                "Beta-catenin",
                "Adenomatous Polyposis Coli",
                "APC"
            ],
            "keywords": [
                "Cancer",
                "Colorectal Cancer",
                "Solid Tumor",
                "Locally Advanced Solid Tumor",
                "Metastatic Cancer",
                "WNT Pathway Activating Mutation (WPAM)",
                "Non-small Cell Lung Cancer (NSCLC)",
                "Gastric Cancer (GC)",
                "Gastroesophageal-junction Cancer (GEJ)",
                "Colorectal Cancer (CRC)",
                "Microsatellite Stable (MSS)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 245,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Part 1a",
                    "type": "EXPERIMENTAL",
                    "description": "Solid Tumors with Any WNT-Pathway Activating Mutations (WPAMs) or Microsatellite Stable (MSS) Colorectal Cancer (Irrespective of WPAM Status)",
                    "interventionNames": [
                        "Drug: FOG-001"
                    ]
                },
                {
                    "label": "Part 1b",
                    "type": "EXPERIMENTAL",
                    "description": "Microsatellite Stable Colorectal Cancer (Irrespective of WPAM Status)",
                    "interventionNames": [
                        "Drug: FOG-001"
                    ]
                },
                {
                    "label": "Cohort 2a",
                    "type": "EXPERIMENTAL",
                    "description": "Microsatellite Stable Colorectal Cancer (Irrespective of WPAM Status)",
                    "interventionNames": [
                        "Drug: FOG-001"
                    ]
                },
                {
                    "label": "Cohort 2b",
                    "type": "EXPERIMENTAL",
                    "description": "Non-Small Cell Lung Cancer with a WNT-Pathway Activating Mutation (WPAM) in Adenomatous Polyposis Coli (APC) or Beta-Catenin",
                    "interventionNames": [
                        "Drug: FOG-001"
                    ]
                },
                {
                    "label": "Cohort 2c",
                    "type": "EXPERIMENTAL",
                    "description": "Gastric Cancer/Gastroesophageal Junction Carcinoma (GEJ) with a WNT-Pathway Activating Mutation (WPAM) in Adenomatous Polyposis Coli (APC) or Beta-Catenin",
                    "interventionNames": [
                        "Drug: FOG-001"
                    ]
                },
                {
                    "label": "Cohort 2d",
                    "type": "EXPERIMENTAL",
                    "description": "Solid Tumors with Any WNT-Pathway Activating Mutations (WPAMs)",
                    "interventionNames": [
                        "Drug: FOG-001"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "FOG-001",
                    "description": "FOG-001 will be administered IV at assigned doses in continuous cycles of 21 or 28 days",
                    "armGroupLabels": [
                        "Part 1a",
                        "Part 1b"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "FOG-001",
                    "description": "FOG-001 will be administered IV once weekly at the preliminary RP2D dose in continuous cycles of 21 or 28 days",
                    "armGroupLabels": [
                        "Cohort 2a",
                        "Cohort 2b",
                        "Cohort 2c",
                        "Cohort 2d"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "During dose escalation and dose expansion measure incidence and severity of treatment emergent adverse events by CTCAE v5.0",
                    "description": "Number and severity of treatment emergent adverse events as assessed by CTCAE v5.0",
                    "timeFrame": "Through study completion, an average of 4 months"
                },
                {
                    "measure": "During dose escalation characterize dose-limiting toxicities (DLTs)",
                    "description": "Incidence of DLTs",
                    "timeFrame": "1 treatment cycle (21 or 28 days)"
                },
                {
                    "measure": "During dose expansion describe the Overall Response Rate using RECIST v1.1",
                    "description": "The rate of objective responses (Partial \\& Complete) using RECIST v1.1",
                    "timeFrame": "Every 56 or 63 days until study completion, approximately 4 months on average"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Plasma concentration (Cmax) of FOG-001",
                    "timeFrame": "During first 2 cycles (42 or 56 days)"
                },
                {
                    "measure": "Time to achieve Cmax (Tmax) of FOG-001 in plasma",
                    "timeFrame": "During first 2 cycles (42 or 56 days)"
                },
                {
                    "measure": "Area under the plasma concentration-time curve (AUC) of FOG-001",
                    "timeFrame": "During first 2 cycles (42 or 56 days)"
                },
                {
                    "measure": "Clearance (CL) of FOG-001 from the plasma",
                    "timeFrame": "During first 2 cycles (42 or 56 days)"
                },
                {
                    "measure": "Terminal half-life (t1/2) of FOG-001 in plasma",
                    "timeFrame": "During first 2 cycles (42 or 56 days)"
                },
                {
                    "measure": "During dose escalation select the preliminary recommended Phase 2 dose and dosing schedule of study drug",
                    "description": "Rate of Dose Limiting Toxicities (DLTs) across dose levels",
                    "timeFrame": "During Cycle 1 (21 or 28 days)"
                },
                {
                    "measure": "During dose escalation Part 1b to evaluate the pharmacodynamic activity in tumors",
                    "description": "Change in tumor Myc expression (on-study compared to baseline)",
                    "timeFrame": "During first 2 cycles (42 or 56 days)"
                },
                {
                    "measure": "During dose escalation and expansion to describe Best Overall Response Rate using RECIST v1.1",
                    "description": "Best response to treatment using RECIST v1.1",
                    "timeFrame": "Every 56 or 63 days until study completion, approximately 4 months on average"
                },
                {
                    "measure": "During dose escalation and expansion to describe Duration of Response using RECIST v1.1",
                    "description": "Time from initial objective response (partial response or complete response) to disease progression",
                    "timeFrame": "Every 56 or 63 days until study completion, approximately 4 months on average"
                },
                {
                    "measure": "During dose expansion describe Progression Free Survival",
                    "description": "Progression Free Survival (PFS) using RECIST v1.1",
                    "timeFrame": "From date of randomization until the date of first disease progression, an average of 4 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.\n* Adequate organ and marrow function.\n\nAdditional Inclusion Criteria for Dose Escalation Cohorts (Part 1a):\n\n* Diagnosis of treatment-refractory advanced/metastatic solid tumor that is non-MSI-H or non-dMMR colorectal cancer (CRC) or any other solid tumor with documented WNT- pathway activating mutations (WPAMs).\n\nAdditional Inclusion Criteria for Dose Escalation Cohorts (Part 1b):\n\n* Diagnosis of treatment-refractory advanced/metastatic non-MSI-H or non-dMMR CRC.\n* At least one lesion that is suitable for a core needle biopsy.\n\nAdditional Inclusion Criteria for Dose Expansion Cohort (Cohort 2a): Colorectal Cancer (CRC) Cohort\n\n* Diagnosis of treatment-refractory advanced/metastatic non-MSI-H or non-dMMR CRC.\n\nAdditional Inclusion Criteria for Dose Expansion Cohort (Cohort 2b): Non-small Cell Lung Cancer (NSCLC) Cohort\n\n* Diagnosis of treatment-refractory advanced/metastatic NSCLC with documented WPAMs in adenomatous polyposis coli (APC) or Beta-catenin.\n\nAdditional Inclusion Criteria for Dose Expansion Cohort (Cohort 2c): Gastric/Gastroesophageal junction (GEJ) Cohort\n\n* Diagnosis of treatment-refractory advanced/metastatic gastric/GEJ cancer with documented WPAMs in APC or Beta-catenin.\n\nAdditional Inclusion Criteria for Dose Expansion Cohort (Cohort 2d): Tumor Agnostic Cohort\n\n* Diagnosis of treatment-refractory advanced/metastatic solid tumor with documented WPAMs.\n\nExclusion Criteria:\n\n* Known history of bone metastasis.\n* Evidence of vertebral compression fracture or non-traumatic bone fracture within the past 12 months and who are not receiving antiresorptive therapy.\n* Osteoporosis, which is defined as a T-score of \\<-2.5 at the lumbar spine (L1 - L4), left (or right) femoral neck or left (or right) total hip as determined by DXA scan, or a FRAX 10-year probability of hip fracture \u22653% or a 10-year probability of major osteoporosis-related fracture \u226520%, based on the US-adapted WHO algorithm for postmenopausal women and men \u226550 years of age.\n* Inflammatory bowel disease (i.e., ulcerative colitis or Crohn's disease) that is recently active or requires therapy currently.\n* Unstable/inadequate cardiac function.\n* Has known meningeal carcinomatosis, leptomeningeal carcinomatosis, spinal cord compression, or symptomatic or unstable brain metastases.\n* Pregnant, lactating, or planning to become pregnant.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Clinical Trial Inquiries",
                    "role": "CONTACT",
                    "phone": "(857) 259-6305",
                    "email": "clinicaltrials@fogpharma.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Marie Nguyen, MD",
                    "affiliation": "Fog Pharmaceuticals, Inc.",
                    "role": "STUDY_CHAIR"
                }
            ],
            "locations": [
                {
                    "facility": "Honor Health",
                    "status": "RECRUITING",
                    "city": "Scottsdale",
                    "state": "Arizona",
                    "zip": "85258",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sunil Sharma, MD",
                            "role": "CONTACT",
                            "phone": "480-323-1350"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.50921,
                        "lon": -111.89903
                    }
                },
                {
                    "facility": "Yale University School of Medicine",
                    "status": "RECRUITING",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06520",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Michael Cecchini, MD",
                            "role": "CONTACT",
                            "phone": "415-302-7807"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Samuel Klempner, MD",
                            "role": "CONTACT",
                            "phone": "617-724-4000"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Washington University School of Medicine",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Moh'd Khushman, MD",
                            "role": "CONTACT",
                            "phone": "314-362-9115"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rona Yaeger, MD",
                            "role": "CONTACT",
                            "phone": "646-888-5109"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Oregon Health and Science University",
                    "status": "RECRUITING",
                    "city": "Portland",
                    "state": "Oregon",
                    "zip": "97239",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Shivaani Kummar, MD",
                            "role": "CONTACT",
                            "phone": "503-494-8534"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.52345,
                        "lon": -122.67621
                    }
                },
                {
                    "facility": "Sarah Cannon Research Institute",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37203",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Meredith S Pelster, MD",
                            "role": "CONTACT",
                            "phone": "615-329-6862"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "The University of Texas MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jordi Rodon Ahnert, MD/PhD",
                            "role": "CONTACT",
                            "phone": "713-792-5603"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "South Texas Accelerated Research Therapeutics, LLC",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kyriakos Papadopoulos, MD",
                            "role": "CONTACT",
                            "phone": "210-593-5255"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008175",
                    "term": "Lung Neoplasms"
                },
                {
                    "id": "D000002289",
                    "term": "Carcinoma, Non-Small-Cell Lung"
                },
                {
                    "id": "D000015179",
                    "term": "Colorectal Neoplasms"
                },
                {
                    "id": "D000013274",
                    "term": "Stomach Neoplasms"
                },
                {
                    "id": "D000009362",
                    "term": "Neoplasm Metastasis"
                },
                {
                    "id": "D000011125",
                    "term": "Adenomatous Polyposis Coli"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000013899",
                    "term": "Thoracic Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000002283",
                    "term": "Carcinoma, Bronchogenic"
                },
                {
                    "id": "D000001984",
                    "term": "Bronchial Neoplasms"
                },
                {
                    "id": "D000007414",
                    "term": "Intestinal Neoplasms"
                },
                {
                    "id": "D000005770",
                    "term": "Gastrointestinal Neoplasms"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000003108",
                    "term": "Colonic Diseases"
                },
                {
                    "id": "D000007410",
                    "term": "Intestinal Diseases"
                },
                {
                    "id": "D000012002",
                    "term": "Rectal Diseases"
                },
                {
                    "id": "D000013272",
                    "term": "Stomach Diseases"
                },
                {
                    "id": "D000009385",
                    "term": "Neoplastic Processes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000018256",
                    "term": "Adenomatous Polyps"
                },
                {
                    "id": "D000000236",
                    "term": "Adenoma"
                },
                {
                    "id": "D000009386",
                    "term": "Neoplastic Syndromes, Hereditary"
                },
                {
                    "id": "D000044483",
                    "term": "Intestinal Polyposis"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "asFound": "Non-small Cell Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "asFound": "Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "asFound": "Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16064",
                    "name": "Stomach Neoplasms",
                    "asFound": "Gastric Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12307",
                    "name": "Neoplasm Metastasis",
                    "asFound": "Metastatic Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14009",
                    "name": "Adenomatous Polyposis Coli",
                    "asFound": "Adenomatous Polyposis Coli",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17890",
                    "name": "Colorectal Neoplasms",
                    "asFound": "Colorectal Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16658",
                    "name": "Thoracic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5540",
                    "name": "Carcinoma, Bronchogenic",
                    "relevance": "LOW"
                },
                {
                    "id": "M5260",
                    "name": "Bronchial Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M10448",
                    "name": "Intestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6336",
                    "name": "Colonic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10444",
                    "name": "Intestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14844",
                    "name": "Rectal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M16062",
                    "name": "Stomach Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12330",
                    "name": "Neoplastic Processes",
                    "relevance": "LOW"
                },
                {
                    "id": "M14011",
                    "name": "Polyps",
                    "relevance": "LOW"
                },
                {
                    "id": "M20402",
                    "name": "Adenomatous Polyps",
                    "relevance": "LOW"
                },
                {
                    "id": "M3591",
                    "name": "Adenoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M12331",
                    "name": "Neoplastic Syndromes, Hereditary",
                    "relevance": "LOW"
                },
                {
                    "id": "M25346",
                    "name": "Intestinal Polyposis",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "T5486",
                    "name": "Stomach Cancer",
                    "relevance": "LOW"
                },
                {
                    "id": "T2191",
                    "name": "Familial Adenomatous Polyposis",
                    "asFound": "Adenomatous Polyposis Coli",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4001",
                    "name": "MYH-associated Polyposis",
                    "asFound": "Adenomatous Polyposis Coli",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}